The genus Aeromonas belongs to the Aeromonadaceae family. A patient with a pancreas–kidney transplant had multiple episodes of abdominal sepsis after surgery. Aeromonas hydrophila was isolated in the ascitic and biliary fluid drains. After discharge, the patient had several diarrhea episodes, and A. hydrophila was isolated in four stool samples. We decided to test whether the one strain that we initially isolated in ascitic fluid was the same that appeared in the successive stool samples. Five isolates of A. hydrophila were found in the patient. Identification was performed using the MALDI-TOF system and confirmed via multiplex PCR. The analysis of the REP-PCR fingerprint patterns showed one cluster and confirmed that all isolates were related. We also demonstrated the virulent character of this species associated with genes encoding different toxins (act, alt, ast, hlyA, and aerA). The virulence of this species is associated with the expression of genes that encode different toxins, structural proteins, and metal-associated proteins. This case report highlights the severity of this disease, especially in immunocompromised patients, and its adequate treatment.
Objectives: Chronic pulmonary aspergillosis (CPA) is a fungal lung infection characterised by the slowly progressing destruction of the lung parenchyma and has four main subtypes. The objective of this work was to evaluate the epidemiology of CPA in our area and evaluate the involvement of the different subtypes in mortality. Methods: This was a descriptive longitudinal retrospective study developed in three tertiary hospitals in Spain. Among all patients admitted with a pulmonary aspergillosis diagnosis, we selected those who fulfilled the criteria for chronic aspergillosis according to the criteria of Denning, excluding those with a haematological disorder. Results: Among 409 inpatients recorded as having a pulmonary aspergillosis infection, only 76 (18.5%) fulfilled the criteria for CPA, with an estimated incidence of 0.67 cases/100,000 inhabitants/year. The subtypes detected were subacute invasive aspergillosis (SAIA) in 33 (43.4%) patients, simple aspergilloma (SA) in 25 (32.9%) patients, cavitary chronic aspergillosis (CCPA) in 13 (17.1%) patients, and chronic fibrosis (CFPA) in five (6.5%) patients. The overall three-month mortality rate was 23%, which was higher in SAIA patients. The predictors of early mortality were age > 65 years (OR 3.0 CI 95 1.0–9.5 p = 0.043) and the SAIA subtype vs. other subtypes (OR 3.1 CI 95 1.0–9.5 p = 0.042). Conclusions: The incidence rate estimated was inferior to that previously reported. The three-month mortality in patients with CPA was high, with older age and the SAIA subtype being the variable independent predictors of a worse prognosis.
Phosphate is a key component of mineralized tissues and is also part of many organic compounds. Phosphorus homeostasis depends especially upon intestinal absorption, and renal excretion, which are regulated by various hormones, such as PTH, 1,25-dihydroxyvitamin D, and fibroblast growth factor 23. In this review we provide an update of several genetic disorders that affect phosphate transporters through cell membranes or the phosphate-regulating hormones, and, consequently, result in hypophosphatemia.
Background: Hereditary hemorrhagic telangiectasia (HHT) shows substantial phenotypic variability. We investigated genotype-phenotype associations, focusing on variant type and predicted effects on RNA processing. Methods: We conducted a retrospective observational study of genetically confirmed HHT patients carrying ENG or ACVRL1 variants. Clinical manifestations, epistaxis severity, treatment and genetic characteristics were assessed. Variants were classified according to molecular type and predicted RNA-disrupting effect. Results: Seventy-eight patients were included, 28 carrying ENG and 50 ACVRL1 variants. Pulmonary arteriovenous malformations (PAVMs) were more frequent among ENG than ACVRL1 carriers (53.6% vs. 24.0%, p = 0.024), whereas hepatic AVMs showed a nonsignificant predominance in ACVRL1 (44.0% vs. 21.4%, p = 0.072). Moderate-to-severe recent epistaxis was more frequent among ACVRL1 carriers (34.0% vs. 3.6%, p = 0.014). Overall, PAVMs were more frequent in patients carrying RNA-disruptive variants than in those with non-RNA-disruptive variants (60.9% vs. 23.6%, p = 0.004). Importantly, this association persisted within ENG, with PAVMs occurring in 73.7% of patients with RNA-disruptive variants compared with 11.1% of those with non-RNA-disruptive variants (p = 0.004). Among patients with non-RNA-disruptive variants, cerebral vascular malformations were more frequent in ENG than in ACVRL1 carriers (44.4% vs. 8.7%, p = 0.013). Conclusions: Beyond established ENG-ACVRL1 phenotypic differences, variant-level molecular characteristics may contribute to HHT phenotypic heterogeneity.